Clinical and Translational Oncology

, Volume 9, Issue 8, pp 513–520 | Cite as

Axillary surgery in breast cancer patients

Reviews
  • 48 Downloads

Abstract

Surgeons have routinely removed ipsilateral axillary lymph nodes from women with breast cancer for over 100 years. The procedure provides important staging information, enhances regional control of the malignancy and may improve survival. As screening of breast cancer has increased, the mean size of newly diagnosed primary invasive breast cancers has steadily decreased and so has the number of women with lymph node metastases. Recognising that the therapeutic benefit of removing normal nodes may be low, alternatives to the routine level I/II axillary lymph node dissection have been sought. A decade ago sentinel lymph node biopsy (SLNB) was introduced. Because of its high accuracy and relatively low morbidity, this technique is now widely used to identify women with histologically involved nodes prior to the formal axillary node dissection. Specifically, SLNB has allowed surgeons to avoid a formal axillary lymph node biopsy in women with histologically uninvolved sentinel nodes, while identifying women with involved sentinel nodes who derive the most benefit from a completion axillary node dissection. Despite the increasing use of SLNB for initial management of the axilla in women with breast cancer, important questions remain regarding patient selection criteria and optimal surgical methods for performing the biopsy. This article discusses the evolution of axillary node surgery for women with breast cancer.

Key words

Breast cancer Therapy Sentinel lymph node biopsy Axillary dissection 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Halsted WS (1898) A clinical and histological study of certain adenocarcinoma of the breast and a brief consideration of the supraclavicular operation and of the results of operation for cancer of the breast from 1989 to 1898 at the Johns Hopkins Hospital. Ann Surg 28:557–576PubMedGoogle Scholar
  2. 2.
    Halsted WS (1894) The results of operations for the cure of cancer of the breast performed at the Johns Hopkins Hospital from June 1889 to January 1894. Ann Surg 20:497–555CrossRefPubMedGoogle Scholar
  3. 3.
    Bonnadonna G, Valagussa P (1988) The contribution of medicine to the primary treatment of breast cancer. Cancer Res 48:2314–2324Google Scholar
  4. 4.
    Lacour J, Bucalossi P, Cacers E et al (1976) Radical mastectomy versus radical mastectomy plus internal mammary dissection. Cancer 37:206–214PubMedCrossRefGoogle Scholar
  5. 5.
    Urban JA, Marjoni MA (1971) Significance of internal mammary lymph node metastases in breast cancer. AJR Am J Roentgenol 111:130–136Google Scholar
  6. 6.
    Veronesi U, Cascinelli N, Mariani L et al (2002) Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347:1227–1232PubMedCrossRefGoogle Scholar
  7. 7.
    Mena A, Garcia A, Moreno L et al (2005) Conservative treatment for infiltrating breast cancer. Ten years follow-up experience. Clin Transl Oncol 8:672–675Google Scholar
  8. 8.
    Monteiro-Grillo I, Marques-Vidal P, Jorge M (2005) Psychosocial effect of mastectomy versus conservative surgery in patients with early breast cancer. Clin Transl Oncol 7:499–503PubMedGoogle Scholar
  9. 9.
    Fisher B, Redmond C, Fisher E et al (1985) Ten year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 312:674–681PubMedCrossRefGoogle Scholar
  10. 10.
    Cancer Research Campaign Working Party (1980) Cancer Research Campaign (King’s/ Cambridge) trial for early breast cancer. Lancet 2:55–60Google Scholar
  11. 11.
    Mittra I (1993) Axillary lymph node metastasis in breast cancer: prognostic indicator or leadtime bias? Eur J Cancer 29:300–302CrossRefGoogle Scholar
  12. 12.
    Giuliano AE, Kigram DM, Guenther JM, Morton DL (1994) Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220:391–401PubMedCrossRefGoogle Scholar
  13. 13.
    Krag DN, Weaver DL, Alex JC, Fairbank JT (1993) Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 2:335PubMedCrossRefGoogle Scholar
  14. 14.
    Uhm JH, Dooley NP, Athanassios P (1999) Vitronectin, a glioma-derived extracellular matrix protein, protects tumor cells form apoptotic death. Clin Cancer Res 5:1587–1594PubMedGoogle Scholar
  15. 15.
    Cassella M, Skobe M (2002) Lymphatic vessel activation in cancer. Ann NY Acad Sci 979:120–130PubMedCrossRefGoogle Scholar
  16. 16.
    Achen MG, Mann GB, Stacker SA (2006) Targeting lymphangiogenesis to prevent tumour metastasis. Br J Cancer 94:1355–1360PubMedCrossRefGoogle Scholar
  17. 17.
    Carr I, Watson P, Petigrew NM (1989) Mechanisms of invasion and lymphatic penetration in human colorectal cancer. Clin Exp Metastasis 7:507–516PubMedCrossRefGoogle Scholar
  18. 18.
    Gervasoni JE, Taneja C, Chung MD, Cady B (2000) Biologic and clinical significance of lymphadenectomy. Surg Clin North Am 80:1631PubMedCrossRefGoogle Scholar
  19. 19.
    Hoon DSB, Korn EL, Cochran AJ (1987) Variations in functional immunocompetence of individual tumor-draining lymph nodes in humans. Cancer Res 47:1740–1744PubMedGoogle Scholar
  20. 20.
    Leong SP (2004) Paradigm of metastasis for melanoma and breast cancer based on the sentinel lymph node experience. Ann Surg Oncol 11:192S–197SPubMedGoogle Scholar
  21. 21.
    Jatoi I (2001) Surgery for primary invasive breast cancer. In: Jatoi I (ed.) Manual of breast diseases. Lippincott, Williams and Wilkins, Philadelphia, pp 289–307Google Scholar
  22. 22.
    Schnitt SJ (2001) Traditional and newer pathologic factors. J Natl Cancer Inst Monogr 30:22–26PubMedGoogle Scholar
  23. 23.
    Heimann R, Hellman S (2000) Clinical progression of breast cancer malignant behavior: what to expect and when to expect it. J Clin Oncol 18:591PubMedGoogle Scholar
  24. 24.
    Cady B (1997) Case against axillary lymphadenectomy for most patients with infiltrating breast cancer. J Surg Oncol 66:7–10PubMedCrossRefGoogle Scholar
  25. 25.
    Mincey BA, Palmieri FM, Perez EA (2002) Adjuvant therapy for breast cancer: recommendations for management based on consensus review and recent clinical trials. Oncologist 7:246–250PubMedCrossRefGoogle Scholar
  26. 26.
    Morrow M (1996) Axillary dissection: when and how radical? Semin Surg Oncol 12:321–327PubMedCrossRefGoogle Scholar
  27. 27.
    Fitzgibbons PL, Page DL, Weaver D et al (2000) Prognostic factors in breast cancer. College of American Pathologists consensus statement 1999. Arch Path Lab Med 124:966–978PubMedGoogle Scholar
  28. 28.
    Liberman L (2000) Pathologic analysis of sentinel lymph nodes in breast carcinoma. Cancer 88:971–977PubMedCrossRefGoogle Scholar
  29. 29.
    Giuliano AE, Dale PS, Turner RR et al (1995) Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 222:394–399PubMedCrossRefGoogle Scholar
  30. 30.
    Braun S, Cevatli BS, Assemi C et al (2001) Comparative analysis of micrometastasis to the bone marrow and lymph nodes of node-negative breast cancer patients receiving. J Clin Oncol 19:1468–1475PubMedGoogle Scholar
  31. 31.
    Singletary SE, Allred C, Ashley P et al (2002) Part VII. Breast. In: Greene FL, Page DL, Fleming ID (eds) American Joint Committee on Cancer Manual (6th Edn). Springer-Verlag, New York, pp 221–240Google Scholar
  32. 32.
    Jatoi I, Hilsenbeck SG, Clark GM, Osborne CK (1999) Significance of axillary lymph node metastasis in primary breast cancer. J Clin Oncol 17:2334–2340PubMedGoogle Scholar
  33. 33.
    Early Breast Cancer Trialists’ Collaborative Group (1998) Polychemotherapy for early breast cancer: an overview of the randomised trials. Lancet 352:930–942CrossRefGoogle Scholar
  34. 34.
    Early Breast Cancer Collaborative Group (1998) Tamoxifen for early breast cancer: an overview of the randomized trials. Lancet 351:1451–1467CrossRefGoogle Scholar
  35. 35.
    Bland KI, Menck HR, Scott-Conner CEH et al (1998) The National Cancer Data Base 10-year survey of breast cancer treatment at hospitals in the United States. Cancer 83:1262–1273PubMedCrossRefGoogle Scholar
  36. 36.
    Wong JS, Recht A, Beard CJ et al (1997) Treatment outcome after tangential radiation therapy without axillary dissection in patients with early stage breast cancer and clinically negative axillary nodes. Int J Radiat Oncol Biol Phys 9:119–132Google Scholar
  37. 37.
    Greco M, Agresti R, Raselli R et al (1996) Axillary dissection can be avoided in selected breast cancer patients: analysis of 401 cases. Anticancer Res 16:3913–3917PubMedGoogle Scholar
  38. 38.
    Silverstein MJ, Gierson ED, Waisman JR et al (1995) Predicting axillary node positivity in patients with invasive carcinoma of the breast by using a combination of T category and palpability. J Am Coll Surg 180:700–704PubMedGoogle Scholar
  39. 39.
    Rosen PP, Groshen S, Saigo PE et al (1989) A long term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma. J Clin Oncol 7:355–366PubMedGoogle Scholar
  40. 40.
    Carter CL, Allen C, Henson DE (1989) Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 63:181–187PubMedCrossRefGoogle Scholar
  41. 41.
    Sacks NP, Baum M (1993) Primary management of carcinoma of the breast. Lancet 342:1402–1408PubMedCrossRefGoogle Scholar
  42. 42.
    Graversen HP, Blichert-Toft M, Andersen J et al (1988) Breast cancer: risk of axillary recurrence in node-negative patients following partial dissection of the axilla. Eur J Surg Oncol 14:407–412PubMedGoogle Scholar
  43. 43.
    Veronesi U, Luini A, Galimberti V et al (1990) Extent of metastatic axillary involvement in 1446 cases of breast cancer. Eur J Surg Oncol 16:127–133PubMedGoogle Scholar
  44. 44.
    Ragaz J, Jackson SM, Le N et al (1997) Adjuvant radiotherapy and chemotherapy in nodepositive premenopausal women with breast cancer. N Engl J Med 337:956–962PubMedCrossRefGoogle Scholar
  45. 45.
    Overgaard M, Hansen PS, Overgaard J et al (1997) Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b. N Engl J Med 337:949–955PubMedCrossRefGoogle Scholar
  46. 46.
    Diab SG, Hilsenbeck SG, de Moor C (1998) Radiation therapy and survival in breast cancer patients with 10 or more positive axillary lymph nodes treated with mastectomy. J Clin Oncol 16:1655–1660PubMedGoogle Scholar
  47. 47.
    Axelsson C, Mouridsen H, Zedeler K (1992) Axillary dissection of level I and II lymph nodes is important in breast cancer classification. The Danish Breast Cancer Cooperative Group (DBCG). Eur J Cancer 28A:1415–1418PubMedCrossRefGoogle Scholar
  48. 48.
    Recht A, Pierce SM, Abner A et al (1991) Regional nodal failure after conservative surgery and radiotherapy for early-stage breast carcinoma. J Clin Oncol 9:988–996PubMedGoogle Scholar
  49. 49.
    Graverson HP, Blichert-Toft M, Andersen J et al (1988) Breast cancer: risk of axillary recurrence in node-negative patients following partial dissection of the axilla. Eur J Surg Oncol 14:407–412Google Scholar
  50. 50.
    Steele RJ, Forrest AP, Gibson T et al (1985) The efficacy of lower axillary sampling in obtaining lymph node status in breast cancer: A controlled randomized trial. Br J Surg 72:368–369PubMedCrossRefGoogle Scholar
  51. 51.
    Kissin MW, Thompson EM, Price AB et al (1982) The inadequacy of axillary sampling in breast cancer. Lancet 1:1210–1212PubMedCrossRefGoogle Scholar
  52. 52.
    Alhlgren J, Holmberg L, Bergh J, Liljegren G (2002) Five-node biopsy of the axilla: an alternative to axillary dissection of levels I-II in operable breast cancer. Eur J Surg Oncol 28:97–102CrossRefGoogle Scholar
  53. 53.
    Macmillan R, Barbera D, Hadjiminas DJ (2001) Sentinel node biopsy for breast cancer may have little to offer four-node-samplers: results of a prospective comparison study. Eur J Cancer 37:1076–1080PubMedCrossRefGoogle Scholar
  54. 54.
    Du Toit RS, Locker AP, Ellis IO et al (1990) Evaluation of the prognostic value of triple node biopsy in early breast cancer. Br J Surg 77:163PubMedCrossRefGoogle Scholar
  55. 55.
    Amalric R, Santamaria F, Robert F et al (1982) Radiation therapy with or without primary limited surgery for operable breast cancer. Cancer 49:30PubMedCrossRefGoogle Scholar
  56. 56.
    Olsen NK, Pfeiffer P, Johannsen L et al (1993) Radiation-induced brachial plexopathy: neurological follow-up in 161recurrence-free breast cancer patients. Int J Radiat Oncol Biol 26:43CrossRefGoogle Scholar
  57. 57.
    Bland KI, Coburn MC (1998) Wound care and complications of mastectomy. In: Bland KI, Copeland EM (eds) The breast. Comprehensive management of benign and malignant diseases. W.B. Saunders Company, Philadelphia, pp 995–1002Google Scholar
  58. 58.
    Liljegren G, Holmberg L, The Upsala-Oregro Breast Cancer Study Group (1997) Arm morbidity after sector resection and axillary dissection with or without postoperative radiotherapy in breast cancer stage I. Results from a randomised trial. Uppsala-Orebro Breast Cancer Study Group. Eur J Cancer 33:193–199PubMedCrossRefGoogle Scholar
  59. 59.
    Hladiuk M, Huchcroft S, Temple W, Schnurr BE (1992) Arm function after axillary dissection for breast cancer. J Surg Oncol 50:47–52PubMedCrossRefGoogle Scholar
  60. 60.
    Gonzalez EA, Saltzstein EC, Riedner CS, Nelson BK (2003) Seroma formation following breast cancer surgery. Breast J 9:385–388PubMedCrossRefGoogle Scholar
  61. 61.
    Reintgen DS, Cox CE, Puleo CA (1998) Lymphedema in the postmastectomy patient: pathophysiology, prevention, and management. In: Bland KI, Copeland EM (eds) The breast. Comprehensive management of benignant and malignant diseases. W.C. Saunders Company, Philadelphia, pp 1003–1011Google Scholar
  62. 62.
    Soran A, D’Angelo G, Begovic M et al (2006) Risk factors and severity of lymphedema. Breast J 12:536–543PubMedCrossRefGoogle Scholar
  63. 63.
    Golshan M, Martin WJ, Dowlatshahi K (2003) Sentinel lymph node biopsy lowers the rate of lymphedema when compared with standard axillary lymph node dissection. Am Surg 69:209–211PubMedGoogle Scholar
  64. 64.
    Chua B, Ung O, Taylor R, Boyages J (2003) Is information from axillary dissection relevant to patients with clinically node-negative breast cancer? Breast J 9:478PubMedCrossRefGoogle Scholar
  65. 65.
    Cody HS (2003) Sentinel lymph node biopsy for breast cancer: does anybody not need one? Ann Surg Oncol 10:1131–1132PubMedCrossRefGoogle Scholar
  66. 66.
    Goldhirsch A, Wood WC, Gelber RD et al (2003) Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer. J Clin Oncol 21:3357–3365PubMedCrossRefGoogle Scholar
  67. 67.
    Martelli G, Miceli R, De Palo G et al (2003) Is axillary lymph node dissection necessary in elderly patients with breast carcinoma who have a clinically uninvolved axilla? Cancer 97:1156–1163PubMedCrossRefGoogle Scholar
  68. 68.
    Martelli G, Borachi P, De Palo M et al (2005) A randomized trial comparing axillary dissection to no axillary dissection in older patients with T1N0 breast cancer. Results after 5 years of follow-up. Ann Surg 242:1–6PubMedCrossRefGoogle Scholar
  69. 69.
    Favret AM, Carlson RW, Goffinet DR et al (2001) Locally advanced breast cancer: is surgery necessary? Breast J 7:131–137PubMedCrossRefGoogle Scholar
  70. 70.
    Veronesi U, Paganelli G, Viale G et al (2003) A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349:546–553PubMedCrossRefGoogle Scholar
  71. 71.
    Schwartz GF, Giuliano AE, Veronesi U (2002) Proceedings of the Consensus Conference on the role of sentinel node biopsy in carcinoma of the breast, April 19–22, 2001, Pennsylvania. Cancer 94:2542–2551PubMedCrossRefGoogle Scholar
  72. 72.
    Van Rijk MC, Tanis PJ, Nieweg OE et al (2006) Clinical implications of sentinel nodes outside the axilla and internal mammary chain in patients with breast cancer. J Surg Oncol 94:266–268CrossRefGoogle Scholar
  73. 73.
    Senn HJ, Thurlimann B, Goldhirsch A et al (2003) Comments on the Saint Gallen consensus 2003 on the Primary Therapy of Early Breast Cancer. Breast 12:569–582PubMedCrossRefGoogle Scholar
  74. 74.
    Recht A (1999) Should irradiation replace dissection for patients with breast cancer with clinically negative axillary lymph nodes? J Surg Oncol 72:184PubMedCrossRefGoogle Scholar
  75. 75.
    Fraile M, Rull M, Julian FJ et al (2000) Sentinel node biopsy as a practical alternative to axillary lymph node dissection in breast cancer patients: an approach to its validity. Ann Oncol 11:701–05PubMedCrossRefGoogle Scholar
  76. 76.
    McMasters KM (2003) The eternally enigmatic axilla: further controversy about axillary lymph nodes in breast cancer. Ann Surg Oncol 10:1128–1130PubMedCrossRefGoogle Scholar
  77. 77.
    Hwang RF, Krishnamurthy S, Hunt KK et al (2003) Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer. Ann Surg Oncol 10:248–254PubMedCrossRefGoogle Scholar
  78. 78.
    Callejo IP, Brito JA, Bivar JW et al (2005) Predictors of positive axillary lymph nodes in breast cancer patients with metastatic sentinel lymph node. Clin Transl Oncol 7:18–22PubMedGoogle Scholar
  79. 79.
    Cserni G, Gregori D, Merlleti F et al (2004) Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer. Br J Surg 91:1245–1252PubMedCrossRefGoogle Scholar
  80. 80.
    Viale G, Maiorano E, Pruneri G et al (2005) Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy. Ann Surg 241:319–325PubMedCrossRefGoogle Scholar
  81. 81.
    Houvenaeghel G, Nos C, Mignotte H et al (2006) Micrometastases in sentinel lymph node in a multicentric study: predictive factors of nonsentinel lymph node involvement — Groupe des Chirurgiens de la Federation des Centres de Lutte Contre le Cancer. J Clin Oncol 24:1814–1822PubMedCrossRefGoogle Scholar
  82. 82.
    Van Rijk MC, Peterse JL, Nieweg OE et al (2006) Additional axillary metastases and stage migration in breast cancer patients with micrometastases or submicrometastases in sentinel lymph nodes. Cancer 107:467–471PubMedCrossRefGoogle Scholar
  83. 83.
    Reynolds C, Mick R, Donohue JH et al (1999) Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer? J Clin Oncol 17:1720–1726PubMedGoogle Scholar
  84. 84.
    Wong SL, Edwards MJ, Chao C et al (2001) Predicting the status of non-sentinel axillary nodes: a multicenter study. Arch Surg 136:563–568PubMedCrossRefGoogle Scholar
  85. 85.
    Jakub JW, Pendas S, Reintgen DS (2003) Current status of sentinel lymph node mapping and biopsy: facts and controversies. Oncologist 8:59–68PubMedCrossRefGoogle Scholar
  86. 86.
    Turner RR, Chu KU, Qi K et al (2000) Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node. Cancer 89:574–581PubMedCrossRefGoogle Scholar
  87. 87.
    Louis-Sylvestre C, Clough K, Asselain B et al (2004) Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up. J Clin Oncol 22:97–101PubMedCrossRefGoogle Scholar
  88. 88.
    Goyal A, Mansel RE (2004) Current status of sentinel lymph node biopsy in solid malignancies. World J Surg Oncol 2(1):9PubMedCrossRefGoogle Scholar
  89. 89.
    Buchholz TA, Strom EA, McNeese M et al (2003) Radiation therapy as an adjuvant treatment after sentinel lymph node surgery for breast cancer. Surg Clin North Am 83:911–930PubMedCrossRefGoogle Scholar
  90. 90.
    Guenther JM, Hansen NM, DiFronzo LA et al (2003) Axillary dissection is not required for all patients with breast cancer and positive sentinel nodes. Arch Surg 138:52–56PubMedCrossRefGoogle Scholar
  91. 91.
    Fant JS, Grant MD, Know SM et al (2003) Preliminary outcome analysis in patients with breast cancer and a positive sentinel lymph node who declined axillary dissection. Ann Surg Oncol 10:126–130PubMedCrossRefGoogle Scholar
  92. 92.
    Langer I, Marti WR, Guller U et al (2005) Axillary recurrence rate in breast cancer patients with negative sentinel lymph node (SLN) or SLN micrometastases: prospective analysis of 150 patients after SLN biopsy. Ann Surg 241:152–158PubMedGoogle Scholar
  93. 93.
    Shimazu K, Tamaki Y, Taguchi T et al (2003) Lymphoscintigraphic visualization of internal mammary nodes with subtumoral injection of radiocolloid in patients with breast cancer. Ann Surg 237:390–398PubMedCrossRefGoogle Scholar
  94. 94.
    Clarke D, Newcombe RG, Mansel RE. ALMANAC Trialists Group (2004) The learning curve in sentinel node biopsy: The ALMANAC experience. Ann Surg Oncol 11[2 Suppl]:2115–2155Google Scholar
  95. 95.
    Wong SL, Edwards MJ, Chao C et al (2002) The effect of prior breast axilla biopsy method and concurrent definitive breast procedure on success and accuracy of sentinel lymph node biopsy. Ann Surg Oncol 9:272–277PubMedCrossRefGoogle Scholar
  96. 96.
    Luini A, Galimberti V, Gatti G et al (2005) The sentinel node biopsy after previous breast surgery: preliminary results on 543 patients treated at the European Institute of Oncology. Breast Cancer Res Treat 89:159–163PubMedCrossRefGoogle Scholar
  97. 97.
    Haigh PI, Hansen NM, Qi K et al (2000) Biopsy method and excision volume do not affect success rate of subsequent sentinel lymph node dissection in breast cancer. Ann Surg Oncol 7:21–27PubMedCrossRefGoogle Scholar
  98. 98.
    Tousimis E, Van Zee KJ, Fey JV et al (2003) The accuracy of sentinel lymph node biopsy in multicentric and multifocal breast cancers. J Am Coll Surg 197:529–535PubMedCrossRefGoogle Scholar
  99. 99.
    Liberman L, Cody HIS (2001) Percutaneous biopsy and sentinel lymphadenectomy: minimally invasive diagnosis and treatment of nonpalpable breast cancer. AJR Am J Roentgenol 177:887–891PubMedGoogle Scholar
  100. 100.
    Dupont EL, Kuhn MA, McCann C et al (2000) The role of sentinel lymph node biopsy in women undergoing prophylactic mastectomy. Am J Surg 180:274–277PubMedCrossRefGoogle Scholar
  101. 101.
    Port ER, Fey J, Gemignani ML et al (2002) Reoperative sentinel lymph node biopsy: a new option for patients with primary or locally recurrent breast carcinoma. J Am Coll Surg 195:167–172PubMedCrossRefGoogle Scholar
  102. 102.
    Mamounas A, Brown A, Anderson S et al (2005) Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol 23:2694–2702PubMedCrossRefGoogle Scholar
  103. 103.
    Stearns V, Ewing CA, Slack R et al (2002) Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer. Ann Surg Oncol 9:235–242PubMedGoogle Scholar
  104. 104.
    Cox CE, Cox JM, White LB et al (2006) Sentinel node biopsy before neoadjuvant chemotherapy for determining axillary status and treatment prognosis in locally advanced breast cancer. Ann Surg Oncol 13:483–490PubMedCrossRefGoogle Scholar
  105. 105.
    Waddington WA, Keshtgar MR, Taylor I et al (2000) Radiation safety of the sentinel lymph node technique in breast cancer. Eur J Nucl Med 27:377–391PubMedCrossRefGoogle Scholar
  106. 106.
    Spetch MC, Fey JV, Borgen PI, Cody HS (2005) Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy? J Am Coll Surg 200:100–104Google Scholar
  107. 107.
    Intra M, Veronesi P, Mazzarol G et al (2003) Axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast. Arch Surg 138:309–313PubMedCrossRefGoogle Scholar
  108. 108.
    González-Palacios Martínez JF (2004) Una nueva modificación en la clasificación TNM del cáncer mamario. Rev Esp Patol 37:247–251Google Scholar
  109. 109.
    Hermanek P, Hutter RVP, Sobin LH, Wittekind C (1999) Classification of isolated tumor cells and micrometastasis. Cancer 86:2668–2673PubMedCrossRefGoogle Scholar
  110. 110.
    Veronesi U, Marubini E, Mariani L et al (1999) The dissection of internal mammary nodes does not improve the survival of breast cancer patients: 30-year results of a randomized trial. Eur J Cancer 35:1320–1325PubMedCrossRefGoogle Scholar
  111. 111.
    Thor A (2004) A revised Staging System for Breast Cancer. Breast J 10[Suppl 1]:S15–S18PubMedCrossRefGoogle Scholar
  112. 112.
    Hortobagyi G (2000) Adjuvant therapy for breast cancer. Annu Rev Med 51:377–392PubMedCrossRefGoogle Scholar

Copyright information

© Feseo 2007

Authors and Affiliations

  1. 1.Division of Breast Diseases. Department of Obstetrics and GynecologyValencia School of MedicineValenciaSpain
  2. 2.Division of Breast Diseases. Department of General SurgeryValencia General HospitalValenciaSpain
  3. 3.Department of Medical OncologyValencia School of MedicineValenciaSpain
  4. 4.Division of Breast Diseases. Department of SurgeryStanford School of MedicinePalo AltoUSA

Personalised recommendations